These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38189623)

  • 1. AAV-Mediated Gene Therapy Restores Hearing in Patients with DFNB9 Deafness.
    Qi J; Tan F; Zhang L; Lu L; Zhang S; Zhai Y; Lu Y; Qian X; Dong W; Zhou Y; Zhang Z; Yang X; Jiang L; Yu C; Liu J; Chen T; Wu L; Tan C; Sun S; Song H; Shu Y; Xu L; Gao X; Li H; Chai R
    Adv Sci (Weinh); 2024 Mar; 11(11):e2306788. PubMed ID: 38189623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model.
    Akil O; Dyka F; Calvet C; Emptoz A; Lahlou G; Nouaille S; Boutet de Monvel J; Hardelin JP; Hauswirth WW; Avan P; Petit C; Safieddine S; Lustig LR
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4496-4501. PubMed ID: 30782832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual-AAV approach restores fast exocytosis and partially rescues auditory function in deaf otoferlin knock-out mice.
    Al-Moyed H; Cepeda AP; Jung S; Moser T; Kügler S; Reisinger E
    EMBO Mol Med; 2019 Jan; 11(1):. PubMed ID: 30509897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Efficacy And Safety Evaluation of AAV-OTOF in DFNB9 Mouse Model And Nonhuman Primate.
    Qi J; Zhang L; Tan F; Zhang Y; Zhou Y; Zhang Z; Wang H; Yu C; Jiang L; Liu J; Chen T; Wu L; Zhang S; Sun S; Sun S; Lu L; Wang Q; Chai R
    Adv Sci (Weinh); 2024 Jan; 11(3):e2306201. PubMed ID: 38014592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hearing of Otof-deficient mice restored by trans-splicing of N- and C-terminal otoferlin.
    Tang H; Wang H; Wang S; Hu SW; Lv J; Xun M; Gao K; Wang F; Chen Y; Wang D; Wang W; Li H; Shu Y
    Hum Genet; 2023 Feb; 142(2):289-304. PubMed ID: 36383253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV1-hOTOF gene therapy for autosomal recessive deafness 9: a single-arm trial.
    Lv J; Wang H; Cheng X; Chen Y; Wang D; Zhang L; Cao Q; Tang H; Hu S; Gao K; Xun M; Wang J; Wang Z; Zhu B; Cui C; Gao Z; Guo L; Yu S; Jiang L; Yin Y; Zhang J; Chen B; Wang W; Chai R; Chen ZY; Li H; Shu Y
    Lancet; 2024 May; 403(10441):2317-2325. PubMed ID: 38280389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral gene therapy in children with autosomal recessive deafness 9: single-arm trial results.
    Wang H; Chen Y; Lv J; Cheng X; Cao Q; Wang D; Zhang L; Zhu B; Shen M; Xu C; Xun M; Wang Z; Tang H; Hu S; Cui C; Jiang L; Yin Y; Guo L; Zhou Y; Han L; Gao Z; Zhang J; Yu S; Gao K; Wang J; Chen B; Wang W; Chen ZY; Li H; Shu Y
    Nat Med; 2024 Jul; 30(7):1898-1904. PubMed ID: 38839897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overloaded Adeno-Associated Virus as a Novel Gene Therapeutic Tool for Otoferlin-Related Deafness.
    Rankovic V; Vogl C; Dörje NM; Bahader I; Duque-Afonso CJ; Thirumalai A; Weber T; Kusch K; Strenzke N; Moser T
    Front Mol Neurosci; 2020; 13():600051. PubMed ID: 33488357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Many Faces of DFNB9: Relating
    Vona B; Rad A; Reisinger E
    Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33256196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature-Sensitive Auditory Neuropathy: Report of a Novel Variant of OTOF Gene and Review of Current Literature.
    Forli F; Capobianco S; Berrettini S; Bruschini L; Romano S; Fogli A; Bertini V; Lazzerini F
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837553
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of a novel splice site variant of OTOF in the Korean nonsyndromic hearing loss population with low prevalence of the OTOF mutations.
    Jin YJ; Park J; Kim AR; Rah YC; Choi BY
    Int J Pediatr Otorhinolaryngol; 2014 Jul; 78(7):1030-5. PubMed ID: 24814232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of acquired sensorineural hearing loss in mice by in vivo Htra2 gene editing.
    Gu X; Wang D; Xu Z; Wang J; Guo L; Chai R; Li G; Shu Y; Li H
    Genome Biol; 2021 Mar; 22(1):86. PubMed ID: 33752742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identities and frequencies of mutations of the otoferlin gene (OTOF) causing DFNB9 deafness in Pakistan.
    Choi BY; Ahmed ZM; Riazuddin S; Bhinder MA; Shahzad M; Husnain T; Riazuddin S; Griffith AJ; Friedman TB
    Clin Genet; 2009 Mar; 75(3):237-43. PubMed ID: 19250381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OTOF mutation analysis with massively parallel DNA sequencing in 2,265 Japanese sensorineural hearing loss patients.
    Iwasa YI; Nishio SY; Sugaya A; Kataoka Y; Kanda Y; Taniguchi M; Nagai K; Naito Y; Ikezono T; Horie R; Sakurai Y; Matsuoka R; Takeda H; Abe S; Kihara C; Ishino T; Morita SY; Iwasaki S; Takahashi M; Ito T; Arai Y; Usami SI
    PLoS One; 2019; 14(5):e0215932. PubMed ID: 31095577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OTOF encodes multiple long and short isoforms: genetic evidence that the long ones underlie recessive deafness DFNB9.
    Yasunaga S; Grati M; Chardenoux S; Smith TN; Friedman TB; Lalwani AK; Wilcox ER; Petit C
    Am J Hum Genet; 2000 Sep; 67(3):591-600. PubMed ID: 10903124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery kinetics of dual AAV-mediated human otoferlin expression.
    Sellon JB; So KS; D'Arcangelo A; Cancelarich S; Drummond MC; Slade PG; Pan N; Gibson TM; Yang T; Burns JC; Palermo AT; Becker L
    Front Mol Neurosci; 2024; 17():1376128. PubMed ID: 38952419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA base editing therapy cures hearing loss induced by OTOF gene mutation.
    Xue Y; Tao Y; Wang X; Wang X; Shu Y; Liu Y; Kang W; Chen S; Cheng Z; Yan B; Xie Y; Bi L; Jia H; Li J; Xiao Q; Chen L; Yao X; Shi L; Yang H; Wu H
    Mol Ther; 2023 Dec; 31(12):3520-3530. PubMed ID: 37915172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hair cell-specific Myo15 promoter-mediated gene therapy rescues hearing in DFNB9 mouse model.
    Wang H; Xun M; Tang H; Zhao J; Hu S; Zhang L; Lv J; Wang D; Chen Y; Liu J; Li GL; Wang W; Shu Y; Li H
    Mol Ther Nucleic Acids; 2024 Mar; 35(1):102135. PubMed ID: 38404504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of the efficacy and safety of AAV1-hOTOF in mice and nonhuman primates.
    Zhang L; Wang H; Xun M; Tang H; Wang J; Lv J; Zhu B; Chen Y; Wang D; Hu S; Gao Z; Liu J; Chen ZY; Chen B; Li H; Shu Y
    Mol Ther Methods Clin Dev; 2023 Dec; 31():101154. PubMed ID: 38027066
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.